Selank vs kava: comparing anxiety relief, evidence, and safety

Last updated 2026-07-26

What are selank and kava, exactly?

Selank is a synthetic peptide, a modified version of the natural immune peptide tuftsin, developed in Russia starting in the 1990s. It's usually taken as a nasal spray and was studied there as an anxiolytic (anti-anxiety agent) with claimed nootropic effects on top. It's not a plant extract or a supplement in the traditional sense; it's a lab-made short chain of amino acids. Kava (Piper methysticum) is a plant native to the South Pacific. People in Fiji, Vanuatu, and Tonga have used kava root as a ceremonial and social drink for centuries. The active compounds are called kavalactones, and Western researchers have actually run a decent number of placebo-controlled human trials on kava extract for anxiety, which is more than can be said for most peptides on the market. So right away, you're comparing two very different categories: a synthetic research peptide with a short, mostly Russian-language trial history, against a traditional herbal anxiolytic with decades of both traditional use and modern Western clinical testing. That difference in evidence pedigree matters more than most comparison articles admit. If you're trying to sort selank from its sibling peptide, note that semax is a related but distinct molecule, derived from ACTH rather than tuftsin, and marketed more for cognition and stroke recovery than pure anxiolysis. People conflate the two constantly because they come from the same era of Russian peptide research.

How does selank's evidence compare to kava's clinical trials?

Kava has multiple randomized, placebo-controlled trials in Western journals. A widely cited 2013 trial published in the Journal of Clinical Psychopharmacology tested an aqueous kava extract in people with generalized anxiety disorder and found a significant reduction in anxiety symptoms versus placebo over 6 weeks ^[1]. A 2003 Cochrane-style systematic review of kava extract for anxiety, published in Psychopharmacology, concluded that kava was "significantly superior to placebo" in reducing anxiety symptoms across pooled trials ^[2]. Selank's evidence base looks different. Most of the pharmacological and clinical work was done by Russian institutions, notably the Institute of Molecular Genetics and the V.V. Zakusov Institute of Pharmacology, and published in Russian-language journals like Eksperimental'naya i Klinicheskaya Farmakologiya (Experimental and Clinical Pharmacology). Some of this work has English abstracts indexed in PubMed, describing anxiolytic effects in small patient groups with generalized anxiety disorder, alongside animal studies on stress models in rats ^[3][4]. These are real, published studies, not internet folklore, but they are small, often lack the double-blind, placebo-controlled rigor standard in US or EU drug trials, and have not been independently replicated by researchers outside Russia. That's the single most useful thing to understand before you spend money on either compound: kava's anxiolytic effect has been tested and mostly confirmed by independent Western trials, while selank's anxiolytic effect rests on a body of Russian clinical and animal research that Western science has not repeated or verified. Neither fact makes selank fake. It just means the confidence level is lower, and you should treat claims about selank with the same skepticism you'd apply to any drug whose entire trial record comes from one country's own institutions.

Is selank or kava better for anxiety?

On paper, kava has the stronger anxiety evidence, at least for generalized anxiety symptoms in adults over weeks of use. The 2013 Journal of Clinical Psychopharmacology trial found meaningful GAD symptom reduction with an aqueous kava extract standardized to kavalactone content ^[1]. That's a real, peer-reviewed, placebo-controlled result from a Western academic setting. Selank's claimed anxiolytic effect, per the Russian literature, is described as occurring faster and without the sedation or dependence risk associated with benzodiazepines, and researchers there have proposed it also carries anxiolytic and antidepressant activity comparable to some conventional anxiolytics in their small trials ^[3]. But because those studies weren't replicated outside Russia, in unrelated labs with independent oversight, you can't put that claim on the same footing as the kava data. In practice: if you want the anxiety compound with an actual Western clinical trial record, kava has it. If you're interested in selank specifically because of its described faster onset or lack of sedation in the Russian literature, understand you're relying on a single country's research infrastructure to vouch for that claim, and Western medicine hasn't independently checked its homework.

What about focus and cognition, more than anxiety?

Kava was never really studied or used for cognitive enhancement; its traditional and clinical use is squarely anxiety and relaxation. If focus or mental sharpness is your actual goal, kava isn't really a contender. Selank, on the other hand, gets marketed as having nootropic properties alongside its anxiolytic effect, largely based on the same Russian research base, including animal studies on memory and learning in stress models ^[4]. Some of that literature also links selank's mechanism to BDNF (brain-derived neurotrophic factor) expression and serotonin/dopamine metabolism changes in rodent studies, though again, this is preclinical and Russian-sourced, not confirmed by independent trials. If cognitive support is genuinely the goal, some people compare selank to its cousin peptide semax, which has a more specific research history around cognitive and neuroprotective effects (including in post-stroke recovery contexts in Russian clinical settings). See the selank vs semax comparison for how the two diverge.

How do the safety profiles compare?

This is where kava has a real, documented problem that selank does not (yet) have any equivalent of. The FDA issued a consumer advisory in 2002 (still referenced in FDA's adverse event tracking) after receiving reports of liver damage, including a small number of cases requiring liver transplant, in people using kava-containing supplements ^[5]. Germany's regulatory agency (BfArM) went further and banned kava products in 2002, though a German court later overturned that ban in 2014 after review of the evidence, and Germany subsequently allowed kava back on the market under tighter conditions ^[6]. The exact mechanism of kava-linked liver injury is still debated. Some researchers point to poor-quality extracts using stems and leaves rather than root (traditional Pacific preparations use only the peeled root), others suggest interactions with alcohol or other hepatotoxic substances, or genetic variability in how people metabolize kavalactones. Either way, the FDA's advisory explicitly names "liver-related injuries" as a real, if uncommon, risk, and it recommends anyone with liver disease or anyone taking other liver-affecting drugs avoid kava entirely ^[5]. Selank's safety data, again, comes almost entirely from Russian trials and animal toxicology work, which reportedly found a favorable safety and tolerability profile at studied doses, with no major organ toxicity signals reported in the literature available ^[3]. But there is no FDA safety monitoring of selank because it isn't an approved or regulated drug or supplement in the US. It's sold as a research chemical. That means there's no equivalent of the FDA's adverse event reporting system actively tracking real-world selank use in the way it tracked kava's liver signal. Absence of reported harm isn't the same as proof of safety at scale; it may just mean far fewer people have used it, for far less time, under far less scrutiny. For a fuller rundown of what's actually been reported with selank, see selank side effects.

Is either one FDA-approved?

No. Neither selank nor kava is an FDA-approved drug for anxiety, depression, or any other condition in the United States. Kava is sold as a dietary supplement in the US, which means it falls under the Dietary Supplement Health and Education Act (DSHEA) framework, not drug approval. The FDA's authority here is limited to post-market safety action, which is exactly what happened with the 2002 liver injury advisory ^[5]. Kava is an approved prescription-strength anxiolytic in some other countries under stricter dosing and extraction standards, but that's not the same as FDA drug approval. Selank has approval status in Russia as a prescription-strength anxiolytic (marketed there under names tied to its peptide identity), reviewed and registered through Russian pharmaceutical regulatory channels. That Russian approval is not equivalent to FDA approval, and it doesn't mean the FDA has reviewed selank's safety or efficacy data at all. In the US, selank is sold and used as a research compound, not a prescribed medication, and buyers should treat it accordingly.

How are they typically dosed and taken?

Kava supplements in the US are typically sold as capsules or tinctures standardized to a kavalactone content, often in the range of 70 to 250 mg of kavalactones per dose in studied trials, taken up to three times daily depending on the product and study protocol ^[1][2]. Traditional Pacific preparations are consumed as a water-based beverage made from ground root, a very different delivery method and dose curve than a standardized Western capsule. Selank is most commonly used as an intranasal spray, with the Russian clinical literature describing doses in the range of a few hundred micrograms per administration, often multiple times daily over a course of days to weeks, mirroring how the Russian trials structured their protocols ^[3][4]. There's no FDA-reviewed dosing guidance for selank in the US, so anything you see cited as a "standard dose" is really an extrapolation from those Russian study protocols, not an independently validated recommendation. For more detail on how people commonly structure a selank protocol, see selank dosage.

How fast do they work, and how long do effects last?

Kava's anxiety-reducing effects in trials built up over the trial period, generally 1 to 6 weeks of consistent dosing, rather than delivering an immediate single-dose anxiolytic hit comparable to a benzodiazepine ^[1][2]. Some users do report a same-day calming and mild sedative effect from a single kava dose, particularly at the higher end of traditional kavalactone content, but the clinical trial data is really about sustained use over weeks. Selank, per the Russian research, is often described as having a fairly quick onset, sometimes within an hour of intranasal administration in small clinical studies, with effects framed as building over a course of daily use across one to several weeks ^[3]. Again, that description comes from a research tradition that Western scientists have not independently replicated, so treat the specific timing claims as directional, not settled fact.

Can you take selank and kava together?

There's no published research, Russian or Western, specifically testing selank and kava combined, so there's no evidence-based answer here, only reasoning by mechanism. Kava's main known risk is liver stress, and it also has documented interactions with alcohol, benzodiazepines, and other CNS depressants, per FDA and clinical toxicology literature ^[5]. Selank isn't described in its research literature as hepatotoxic or as a CNS depressant in the same category, so a straightforward pharmacological red flag isn't obvious. But "no known interaction" is not the same as "studied and cleared." Nobody has run a real trial on the combination, so anyone stacking them is doing so on their own, without a safety net of actual data. If you have any liver condition, or take other medications metabolized by the liver, the more conservative move is to not add another unknown variable, especially since selank's own long-term safety data outside Russian trials is thin.

Which one has better quality control and sourcing?

Kava, as a regulated dietary supplement category in the US, is subject to the FDA's Current Good Manufacturing Practice (cGMP) requirements for dietary supplements under 21 CFR Part 111, which cover identity, purity, and manufacturing controls, though enforcement and testing rigor still vary a lot by brand ^[7]. Reputable kava sellers will disclose kavalactone content and often specify root-only sourcing to avoid the aerial-parts contamination issue linked to some liver injury cases. Selank is not a dietary supplement in the US; it's sold through research chemical channels, which means it doesn't fall under DSHEA or cGMP dietary supplement rules at all. Quality control is entirely dependent on which supplier you use and whether they provide third-party purity testing (like a certificate of analysis). This is the part of the selank market that varies wildly, from labs doing real testing to sellers with no verification at all. If you're going to use selank, going through a provider-reviewed sourcing route matters more than with most supplements, precisely because there's no regulatory floor underneath it the way there is with kava. Selank Co reviews providers and points to a specific fulfilling pharmacy partner rather than selling or compounding anything itself, which is a meaningfully different model than an unverified research chemical storefront. For the general landscape of where people buy it and what to check, see buy selank.

Selank vs kava at a glance

So which should you actually try?

If you want the option with an actual Western clinical trial record behind its anxiety claim, that's kava, with the tradeoff being a documented, if uncommon, liver injury risk that the FDA has formally flagged ^[5]. If you have any liver history, or drink regularly, that risk profile alone might rule it out for you. If you're drawn to selank because of its described lack of sedation, faster onset, or added nootropic angle, know clearly that you're relying on Russian research that Western science hasn't replicated. That's not a dismissal of the data; it's real pharmacological work done by real institutions like the Zakusov Institute. But it's also not the same evidentiary weight as a peer-reviewed, Western, placebo-controlled trial. Treat it as promising but unconfirmed, and source it carefully given the lack of any dietary-supplement-style regulatory floor. Start with the selank overview if you want the full evidence rundown before deciding anything.

Frequently asked questions

Is selank stronger than kava for anxiety?

There's no head-to-head trial comparing them directly. Kava has more independently replicated Western trial evidence for anxiety reduction; selank's anxiolytic claims come mostly from Russian clinical studies that haven't been repeated outside Russia. "Stronger" isn't really answerable without a shared trial, so treat any claim either way as unverified.

Does kava cause liver damage?

Rarely, but yes, according to FDA reports. The FDA issued a 2002 advisory after receiving reports of liver injury, including cases requiring transplant, linked to kava supplements. Germany initially banned kava in 2002 over the same concern, then reversed the ban in 2014 after further review of extraction methods and evidence quality.

Is selank safe for the liver?

Published Russian toxicology and clinical literature on selank hasn't reported major organ toxicity signals, but there's no FDA or independent Western monitoring system tracking selank's real-world safety the way there is for kava. Fewer people have used it, for less time, under less scrutiny, so absence of reported harm isn't proof of safety at scale.

Is selank the same as semax?

No. Selank and semax are related Russian-developed peptides but structurally and functionally different. Selank derives from tuftsin and is studied mainly as an anxiolytic; semax derives from ACTH and is studied more for cognitive and neuroprotective effects, including stroke recovery contexts. See the selank vs semax comparison for details.

Can you buy kava and selank legally in the US?

Kava is legal and sold as a dietary supplement in the US, regulated under DSHEA and FDA supplement manufacturing rules. Selank is not FDA-approved as a drug or supplement; it's sold through research chemical channels, which means sourcing and purity verification depend entirely on the specific seller.

Does selank have any FDA approval at all?

No. Selank has prescription drug approval in Russia but no FDA review or approval status in the United States. It's sold in the US as a research compound, not a prescribed or over-the-counter medication, so there's no FDA safety or efficacy data on it.

How long does it take kava to work for anxiety?

Clinical trials on kava generally measured anxiety symptom reduction over 1 to 6 weeks of consistent daily dosing, not a single-dose effect. Some users report same-day mild calming from one dose, but the controlled trial evidence is about sustained use, not immediate relief.

Are there interactions between selank and kava?

No published research has tested the combination. Kava carries known interaction risks with alcohol, benzodiazepines, and other liver-affecting substances. Selank isn't described as hepatotoxic in its research literature, but that combination has never been formally studied, so any stacking is done without real safety data behind it.

Why is most of the selank research in Russian?

Selank was developed and studied primarily by Russian institutions, including the Institute of Molecular Genetics and the V.V. Zakusov Institute of Pharmacology, starting in the 1990s. Western pharmaceutical research hasn't picked up independent replication of these trials, so the evidence base remains concentrated in Russian-language clinical and pharmacology journals.

Is kava a nootropic like selank claims to be?

No. Kava's traditional and clinical use is centered on anxiety reduction and relaxation, not cognitive enhancement. Selank is marketed with added nootropic claims based on Russian animal and small clinical studies on memory and stress response, a different claim category than anything kava research covers.

Which has fewer reported side effects, selank or kava?

Kava has a documented, though rare, serious side effect (liver injury) tracked by the FDA. Selank's Russian literature reports a favorable tolerability profile with no major toxicity signals, but it lacks the scale of real-world monitoring that surfaced kava's liver signal, so the comparison isn't apples to apples.

Do I need a prescription for either one?

Kava does not require a prescription in the US; it's sold over the counter as a supplement. Selank requires a prescription in Russia where it's an approved drug, but in the US it isn't a prescribed medication at all; it's obtained through research chemical or compounding pharmacy channels depending on the source.

Sources

1. Journal of Clinical Psychopharmacology, Sarris et al. 2013: Aqueous kava extract significantly reduced anxiety symptoms versus placebo in a randomized controlled trial for GAD
2. Psychopharmacology, Pittler & Ernst 2003 systematic review: Kava extract was found significantly superior to placebo for anxiety symptom reduction across pooled trials
3. Eksperimental'naya i Klinicheskaya Farmakologiya / PubMed abstract on selank clinical study: Russian clinical study describing selank's anxiolytic effects and tolerability in patients with generalized anxiety disorder
4. PubMed abstract, selank animal/preclinical pharmacology study: Preclinical research on selank's effects on stress response and behavior in animal models
5. U.S. Food and Drug Administration, Kava-Containing Dietary Supplements Consumer Advisory (2002): FDA advisory on reports of liver-related injury, including cases requiring transplant, linked to kava-containing dietary supplements
6. BfArM / German kava ban reversal reporting: Germany's kava ban, originally imposed in 2002 over liver toxicity concerns, was overturned in 2014 after regulatory and court review
7. FDA, 21 CFR Part 111 Current Good Manufacturing Practice for Dietary Supplements: Dietary supplements including kava products are subject to FDA cGMP identity, purity, and manufacturing regulations